Company intelligence / Profile preview

Northleaf Capital Partners

Ownership: Private
Employees: ~275
Development stage: Other

Overview

Northleaf Capital Partners is a global private markets investment firm with more than US$28 billion in commitments across private equity, venture capital/growth equity, private credit, and infrastructure. The firm focuses on mid-market companies and assets globally. It has an established track record investing directly and through funds in sectors including technology and healthcare. Recent funds include the Northleaf Growth Fund targeting high-potential growth-stage companies in tech and healthcare.

Industry: Investors

Partnerships

Partnerships with leading fund managers for co-investments and secondary transactions.

Beyond the preview

Go deeper on Northleaf Capital Partners.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Northleaf Capital Partners.

Explore the full profile